4.5 Article

Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery

Journal

ADVANCES IN WOUND CARE
Volume 10, Issue 9, Pages 503-528

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/wound.2020.1167

Keywords

chronic wound; drug delivery; gene therapy; nucleic acids; wound healing; biomaterials

Categories

Funding

  1. Army Research Office [W911NF-18-2-0048]
  2. NIH [1R01CA235375]

Ask authors/readers for more resources

Despite new understanding in the biology of impaired wound healing, little progress has been made in treating chronic wounds. Diabetic ulcers are a common form of nonhealing wounds. Recently, research on therapeutic nucleic acids has shown promise in creating a new treatment strategy for chronic wounds.
Significance:Nonhealing wounds have been the subject of decades of basic and clinical research. Despite new knowledge about the biology of impaired wound healing, little progress has been made in treating chronic wounds, leaving patients with few therapeutic options. Diabetic ulcers are a particularly common form of nonhealing wound. Recent Advances:Recently, investigation of therapeutic nucleic acids (TNAs), including plasmid DNA, small interfering RNA, microRNA mimics, anti-microRNA oligonucleotides, messenger RNA, and antisense oligonucleotides, has created a new treatment strategy for chronic wounds. TNAs can modulate the wound toward a prohealing environment by targeting gene pathways associated with inflammation, proteases, cell motility, angiogenesis, epithelialization, and oxidative stress. A variety of delivery systems have been investigated for TNAs, including dendrimers, lipid nanoparticles (NPs), polymeric micelles, polyplexes, metal NPs, and hydrogels. This review summarizes recent developments in TNA delivery for therapeutic targets associated with chronic wounds, with an emphasis on diabetic ulcers. Critical Issues:Translational potential of TNAs remains a key challenge; we highlight some drug delivery approaches for TNAs that may hold promise. We also describe current commercial efforts to locally deliver nucleic acids to modulate the wound environment. Future Directions:Localized nucleic acid delivery holds promise for the treatment of nonhealing chronic wounds. Future efforts to improve targeting of these nucleic acid therapies in the wound with both spatial and temporal control through drug delivery systems will be crucial to successful clinical translation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available